Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening

por Adasme, Melissa F., Bolz, Sarah Naomi, Al-Fatlawi, Ali, Schroeder, Michael
Publicado 2022

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs

por Parisi, Daniele, Adasme, Melissa F., Sveshnikova, Anastasia, Bolz, Sarah Naomi, Moreau, Yves, Schroeder, Michael
Publicado 2020

Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

por Bolz, Sarah Naomi, Salentin, Sebastian, Jennings, Gary, Haupt, V. Joachim, Sterneckert, Jared, Schroeder, Michael
Publicado 2021

PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA

por Adasme, Melissa F, Linnemann, Katja L, Bolz, Sarah Naomi, Kaiser, Florian, Salentin, Sebastian, Haupt, V Joachim, Schroeder, Michael
Publicado 2021

Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants

por Al-Fatlawi, Ali, Malekian, Negin, García, Sebastián, Henschel, Andreas, Kim, Ilwook, Dahl, Andreas, Jahnke, Beatrix, Bailey, Peter, Bolz, Sarah Naomi, Poetsch, Anna R., Mahler, Sandra, Grützmann, Robert, Pilarsky, Christian, Schroeder, Michael
Publicado 2021

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning

por Adasme, Melissa F., Bolz, Sarah Naomi, Adelmann, Lauren, Salentin, Sebastian, Haupt, V. Joachim, Moreno-Rodríguez, Adriana, Nogueda-Torres, Benjamín, Castillo-Campos, Verónica, Yepez-Mulia, Lilián, De Fuentes-Vicente, José A., Rivera, Gildardo, Schroeder, Michael
Publicado 2020